Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rang in Aktien #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Aktienkurs
$50.95
Marktkapitalisierung
$226.41B
Veränderung (1 Tag)
2.58%
Veränderung (1 Jahr)
-26.16%
Land
DK
Handel Novo Nordisk A/S (NVO)

Kategorie

Aktien-Split-Historie für Novo Nordisk A/S (NVO)
Die Aktie Novo Nordisk A/S (Symbol: NVO) durchlief insgesamt 5 Aktiensplits.
Der letzte Aktiensplit fand am Sep 20, 2023 statt.
Eine NVO-Aktie, die vor dem Apr 18, 1994 gekauft wurde, entspricht heute 200 NVO-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2023-09-20 2:1 x2 x200
2014-01-09 5:1 x5 x100
2007-12-17 2:1 x2 x20
2001-04-11 5:2 x2.5 x10
1994-04-18 4:1 x4 x4
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
US
0 -
BE
0 -
NL
0 -
US